Herantis Pharma

Biotech & Life Sciences · Helsinki, Finland · Founded 2008 · IPO 2014

Innovative biotech company developing disease modifying therapies for Parkinson’s disease MoreLess

Herantis Pharma PLC is a biotech company developing disease-modifying therapies for Parkinson's disease. The company's current development program focuses solely on HER-096, which is a peptidomimetic molecule designed to retain the biological activity of the neuroprotective CDNF protein. Keywords: Pharmaceuticals and Biotechnology, Biologics, Biotech, Drug Development Firm, Drugs Researchers, Neurodegenerative Diseases, Neurodegenerative Diseases Drugs, Neurodegenerative Diseases Medicine.

Valuation $28M

Revenue $28K

Total funding $10–50M

Talent graph

Herantis Pharma's talent

Book a demo to see the people

Team profiled 10 named & role-tagged

Founders /100 quality score

Key operators 4 quality /100

Potential founders likely future founders

Startup mafia alumni-founded startups

Talent movements in · out past 12 months

Source: Dealroom Talent Intelligence.

Investors

6 investors on Herantis Pharma's cap table

Sourced from Dealroom's funding and investor records.

Seed 3 investors entered at this stage

European Innovation Council

Parkinson's Virtual Biotech

Michael J. Fox Foundation for Parkinson's Research

Series A 2 investors entered at this stage

Finnvera Venture Capital

VNT Management

Series B+ 1 investor entered at this stage

EIC Fund

Global footprint

Where Herantis Pharma has talent and traffic

Workforce by country

4 countries with
team presence

🇫🇮 Finland78.6%

🇮🇹 Italy7.1%

🇺🇸 United States7.1%

🇩🇰 Denmark7.1%

4 countries shown

Market sentiment

What the market is saying about Herantis Pharma

An AI-synthesized read of the highest-engagement posts about Herantis Pharma on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Herantis Pharma on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles